Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment

An extended-release formulation of nevirapine (NVP-XR) has been developed with the aim of simplifying antiretroviral treatment regimens and improving patients’ adherence with a single daily intake. The VERxVE and TRANxITION clinical trials have demonstrated the noninferiority of NVP-XR compared with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yone, Eric W Pefura, Kengne, André P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520460/
https://www.ncbi.nlm.nih.gov/pubmed/23248575
http://dx.doi.org/10.2147/HIV.S24432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520460/
https://www.ncbi.nlm.nih.gov/pubmed/23248575
http://dx.doi.org/10.2147/HIV.S24432

Ejemplares similares